HLOSF
Price
$3.44
Change
+$0.73 (+27.04%)
Updated
Jul 14 closing price
Capitalization
469.93M
LGVN
Price
$1.67
Change
-$0.02 (-1.18%)
Updated
Jul 25 closing price
Capitalization
25.07M
Interact to see
Advertisement

HLOSF vs LGVN

Header iconHLOSF vs LGVN Comparison
Open Charts HLOSF vs LGVNBanner chart's image
HEALIOS K K
Price$3.44
Change+$0.73 (+27.04%)
Volume$100
Capitalization469.93M
Longeveron
Price$1.67
Change-$0.02 (-1.18%)
Volume$118.34K
Capitalization25.07M
HLOSF vs LGVN Comparison Chart in %
Loading...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLOSF vs. LGVN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLOSF is a Buy and LGVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (HLOSF: $3.43 vs. LGVN: $1.67)
Brand notoriety: HLOSF and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HLOSF: 80% vs. LGVN: 26%
Market capitalization -- HLOSF: $469.93M vs. LGVN: $25.07M
HLOSF [@Biotechnology] is valued at $469.93M. LGVN’s [@Biotechnology] market capitalization is $25.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLOSF’s FA Score shows that 0 FA rating(s) are green whileLGVN’s FA Score has 1 green FA rating(s).

  • HLOSF’s FA Score: 0 green, 5 red.
  • LGVN’s FA Score: 1 green, 4 red.
According to our system of comparison, LGVN is a better buy in the long-term than HLOSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLOSF’s TA Score shows that 3 TA indicator(s) are bullish while LGVN’s TA Score has 6 bullish TA indicator(s).

  • HLOSF’s TA Score: 3 bullish, 2 bearish.
  • LGVN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, LGVN is a better buy in the short-term than HLOSF.

Price Growth

HLOSF (@Biotechnology) experienced а 0.00% price change this week, while LGVN (@Biotechnology) price change was +9.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

LGVN is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLOSF($470M) has a higher market cap than LGVN($25.1M). HLOSF YTD gains are higher at: 154.444 vs. LGVN (-3.468). LGVN has higher annual earnings (EBITDA): -16.49M vs. HLOSF (-2.39B). HLOSF has more cash in the bank: 8.89B vs. LGVN (14.3M). LGVN has less debt than HLOSF: LGVN (1.3M) vs HLOSF (6.1B). HLOSF has higher revenues than LGVN: HLOSF (521M) vs LGVN (2.23M).
HLOSFLGVNHLOSF / LGVN
Capitalization470M25.1M1,873%
EBITDA-2.39B-16.49M14,521%
Gain YTD154.444-3.468-4,453%
P/E RatioN/AN/A-
Revenue521M2.23M23,416%
Total Cash8.89B14.3M62,196%
Total Debt6.1B1.3M470,965%
TECHNICAL ANALYSIS
Technical Analysis
HLOSFLGVN
RSI
ODDS (%)
Bearish Trend 2 days ago
40%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
13%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
10%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 24 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
24%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UTSI2.510.03
+1.23%
UTStarcom Holdings Corp
MFC31.320.18
+0.58%
Manulife Financial Corp
GOLF82.340.17
+0.21%
Acushnet Holdings Corp
MFIC13.03N/A
N/A
MidCap Financial Investment Corp
ISOU7.47-0.13
-1.71%
IsoEnergy Ltd

HLOSF and

Correlation & Price change

A.I.dvisor tells us that HLOSF and BRTX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLOSF and BRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLOSF
1D Price
Change %
HLOSF100%
N/A
BRTX - HLOSF
23%
Poorly correlated
-1.52%
LGVN - HLOSF
22%
Poorly correlated
-1.18%
ENTBF - HLOSF
7%
Poorly correlated
N/A
CPMV - HLOSF
5%
Poorly correlated
+25.37%
SLN - HLOSF
3%
Poorly correlated
+0.96%
More

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with RXRX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-1.18%
RXRX - LGVN
44%
Loosely correlated
+3.67%
PROK - LGVN
39%
Loosely correlated
+0.92%
QURE - LGVN
37%
Loosely correlated
-0.66%
IMNM - LGVN
36%
Loosely correlated
-3.29%
SNGX - LGVN
36%
Loosely correlated
-5.04%
More